Rabies ribonucleocapsid as an oral immunogen and immunological enhancer. 1994

D C Hooper, and I Pierard, and A Modelska, and L Otvos, and Z F Fu, and H Koprowski, and B Dietzschold
Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107-6799.

The administration of rabies ribonucleocapsid (RNP) by oral as well as parenteral routes was found to prime specific T cells and elicit N-protein-specific antibodies. per os and intramuscular immunization led to the production of antibodies of the IgA and IgG isotypes, respectively. Mice primed orally with RNP produced significantly enhanced amounts of virus-neutralizing antibody, compared with non-immune controls, upon subsequent parenteral booster immunization with inactivated rabies virus. Thus oral immunization with rabies RNP primed cells capable of mediating a secondary systemic response to rabies virus. The results of experiments in which peptide and protein antigens were administered either physically coupled to or mixed with RNP indicate that RNP has an inherent capacity to enhance immune responses.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D011820 Rabies virus The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates. Rabies viruses
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D005260 Female Females
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

D C Hooper, and I Pierard, and A Modelska, and L Otvos, and Z F Fu, and H Koprowski, and B Dietzschold
November 2016, Journal of the American Chemical Society,
D C Hooper, and I Pierard, and A Modelska, and L Otvos, and Z F Fu, and H Koprowski, and B Dietzschold
October 2007, Current gene therapy,
D C Hooper, and I Pierard, and A Modelska, and L Otvos, and Z F Fu, and H Koprowski, and B Dietzschold
November 2006, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
D C Hooper, and I Pierard, and A Modelska, and L Otvos, and Z F Fu, and H Koprowski, and B Dietzschold
January 1998, Methods in molecular biology (Clifton, N.J.),
D C Hooper, and I Pierard, and A Modelska, and L Otvos, and Z F Fu, and H Koprowski, and B Dietzschold
April 2012, Vaccine,
D C Hooper, and I Pierard, and A Modelska, and L Otvos, and Z F Fu, and H Koprowski, and B Dietzschold
January 1988, Reviews of infectious diseases,
D C Hooper, and I Pierard, and A Modelska, and L Otvos, and Z F Fu, and H Koprowski, and B Dietzschold
January 2015, Biological & pharmaceutical bulletin,
D C Hooper, and I Pierard, and A Modelska, and L Otvos, and Z F Fu, and H Koprowski, and B Dietzschold
January 2023, Journal of inflammation research,
D C Hooper, and I Pierard, and A Modelska, and L Otvos, and Z F Fu, and H Koprowski, and B Dietzschold
January 1977, Immunological communications,
D C Hooper, and I Pierard, and A Modelska, and L Otvos, and Z F Fu, and H Koprowski, and B Dietzschold
June 1986, American journal of diseases of children (1960),
Copied contents to your clipboard!